A historical perspective on ACE2 in the COVID-19 era

被引:37
作者
Bhalla, Vivek [1 ,2 ,3 ]
Blish, Catherine A. [3 ,4 ,5 ]
South, Andrew M. [6 ,7 ,8 ]
机构
[1] Stanford Univ, Sch Med, Stanford Hypertens Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Div Nephrol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
[5] Chan Zuckerberg Biohub, San Francisco, CA USA
[6] Wake Forest Sch Med, Brenner Childrens Hosp, Dept Pediat, Sect Nephrol, Winston Salem, NC 27101 USA
[7] Wake Forest Sch Med, Dept Surg Hypertens & Vasc Res, Winston Salem, NC 27101 USA
[8] Wake Forest Sch Med, Dept Epidemiol & Prevent, Div Publ Hlth Sci, Winston Salem, NC 27101 USA
关键词
ANGIOTENSIN-CONVERTING ENZYME; AMINO ACID COMPOSITION; RECEPTOR; INHIBITORS; CORONAVIRUS; EXPRESSION; IDENTIFICATION; ANTAGONIST; CAPTOPRIL; BLOCKADE;
D O I
10.1038/s41371-020-00459-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:935 / 939
页数:5
相关论文
共 41 条
  • [1] ANTIHYPERTENSIVE ACTIONS OF ANGIOTENSIN-(1-7) IN SPONTANEOUSLY HYPERTENSIVE RATS
    BENTER, IF
    FERRARIO, CM
    MORRIS, M
    DIZ, DI
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (01): : H313 - H319
  • [2] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL SERIES OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR-BINDING INHIBITORS SPECIFIC FOR THE AT2 SUBTYPE
    BLANKLEY, CJ
    HODGES, JC
    KLUTCHKO, SR
    HIMMELSBACH, RJ
    CHUCHOLOWSKI, A
    CONNOLLY, CJ
    NEERGAARD, SJ
    VANNIEUWENHZE, MS
    SEBASTIAN, A
    QUIN, J
    ESSENBURG, AD
    COHEN, DM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (11) : 3248 - 3260
  • [3] Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls
    Byrd, J. Brian
    Chertow, Glenn M.
    Bhalla, Vivek
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (17) : 1589 - 1591
  • [4] CARDIOVASCULAR EFFECTS OF ANGIOTENSIN-(1-7) INJECTED INTO THE DORSAL MEDULLA OF RATS
    CAMPAGNOLESANTOS, MJ
    DIZ, DI
    SANTOS, RAS
    KHOSLA, MC
    BROSNIHAN, KB
    FERRARIO, CM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (01): : H324 - H329
  • [5] CHAPPELL MC, 1989, J BIOL CHEM, V264, P16518
  • [6] Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19
    Curfman, Gregory
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02): : 177 - 178
  • [7] HISTORY OF THE DESIGN OF CAPTOPRIL AND RELATED INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME
    CUSHMAN, DW
    ONDETTI, MA
    [J]. HYPERTENSION, 1991, 17 (04) : 589 - 592
  • [8] A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
    Donoghue, M
    Hsieh, F
    Baronas, E
    Godbout, K
    Gosselin, M
    Stagliano, N
    Donovan, M
    Woolf, B
    Robison, K
    Jeyaseelan, R
    Breitbart, RE
    Acton, S
    [J]. CIRCULATION RESEARCH, 2000, 87 (05) : E1 - E9
  • [9] Identification of a novel coronavirus in patients with severe acute respiratory syndrome
    Drosten, C
    Günther, S
    Preiser, W
    van der Werf, S
    Brodt, HR
    Becker, S
    Rabenau, H
    Panning, M
    Kolesnikova, L
    Fouchier, RAM
    Berger, A
    Burguière, AM
    Cinatl, J
    Eickmann, M
    Escriou, N
    Grywna, K
    Kramme, S
    Manuguerra, JC
    Müller, S
    Rickerts, V
    Stürmer, M
    Vieth, S
    Klenk, HD
    Osterhaus, ADME
    Schmitz, H
    Doerr, HW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) : 1967 - 1976
  • [10] THE DISCOVERY OF DUP-753, A POTENT, ORALLY ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    DUNCIA, JV
    CARINI, DJ
    CHIU, AT
    JOHNSON, AL
    PRICE, WA
    WONG, PC
    WEXLER, RR
    TIMMERMANS, PBMWM
    [J]. MEDICINAL RESEARCH REVIEWS, 1992, 12 (02) : 149 - 191